Billable / Specific Code
ICD-10-CM L92.1 is the diagnosis code for Necrobiosis lipoidica, not elsewhere classified. This code falls under the section "Other disorders of the skin and subcutaneous tissue" within Chapter 12 — Diseases of the skin and subcutaneous tissue (L00-L99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as L92.1. They are mutually exclusive:
Understanding where L92.1 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, L92.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
L92.1 is the ICD-10-CM diagnosis code for "Necrobiosis lipoidica, not elsewhere classified". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of L92.1 is L92 ("Granulomatous disorders of skin and subcutaneous tissue"). L92.1 provides a more specific classification within this category.
L92.1 is located in Section L80-L99 — "Other disorders of the skin and subcutaneous tissue" within Chapter 12 of the ICD-10-CM Tabular List.
Use L92.1 when the patients documented diagnosis matches "Necrobiosis lipoidica, not elsewhere classified" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Necrobiosis lipoidica, not elsewhere classified is L92.1.
Yes, L92.1 can be used as a primary diagnosis code since it is billable and specific.
L92.1 is in Chapter 12 of the ICD-10-CM Tabular List.
Type 1 Excludes for L92.1 include: necrobiosis lipoidica associated with diabetes mellitus (E08-E13 with .620).
Yes, L92.1 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.